title: Extensive rhabdomyolysis after streptokinase therapy for acute myocardial infarction demonstrated by Tc-99m PYP scintigraphy.
authors.affiliation: Department of Nuclear Medicine, Concord Hospital, Australia.
authors.forename: L M
authors.initials: LM
authors.lastname: Emmett
authors.forename: N C
authors.initials: NC
authors.lastname: Patel
authors.forename: K
authors.initials: K
authors.lastname: Thanakrishnan
authors.forename: H
authors.initials: H
authors.lastname: Van der Wall
authors.forename: M
authors.initials: M
authors.lastname: Magee
authors.forename: K C
authors.initials: KC
authors.lastname: Allman
mesh_terms: D000368:Aged; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000139:chemically induced / Q000628:therapy; D012206:Rhabdomyolysis / Q000139:chemically induced / Q000000981:diagnostic imaging*; D013300:Streptokinase / Q000009:adverse effects*; D016698:Technetium Tc 99m Pyrophosphate; D015912:Thrombolytic Therapy / Q000009:adverse effects; D014915:Whole-Body Counting
chemical_list: D005343:Fibrinolytic Agents; D019275:Radiopharmaceuticals; D016698:Technetium Tc 99m Pyrophosphate; D013300:Streptokinase